__NUXT_JSONP__("/drugs/Temoporfin", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[{activeSubstance:b,conditionIndication:"Foscan is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.",inn:b,marketingAuthorisationDate:"2001-10-24 00:00:00",marketingAuthorisationHolder:"Biolitec Pharma Ltd",medicineName:c,url:"https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fmedicines\u002Fhuman\u002FEPAR\u002Ffoscan"}],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"122341-38-2",chebiId:"CHEBI:9437",chemicalFormula:"C44H32N4O4",definition:"A synthetic light-activated chlorin with photodynamic activity. Upon systemic administration, temoporfin distributes throughout the body and is taken up by tumor cells. Upon stimulation of temoporfin by non-thermal laser light (at 652 nm), and in the presence of oxygen, this agent produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to tumor cells. This may kill tumor cells and may reduce the tumor size.",fdaUniiCode:"FU21S769PF",identifier:"C1669",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C1420"],synonyms:["5,10,15,20-Tetra-(m-hydroxyphenyl)chlorin",c,"TEMOPORFIN",a,"m-Tetrahydroxyphenyl-chlorin","mTHPC","meta-Tetrahydroxyphenyl Chlorin","meta-Tetrahydroxyphenylchlorin",b]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTemoporfin",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Temoporfin","temoporfin","Foscan","2021-10-30T13:35:47.383Z")));